![DPP4/CD32b/NF-κB Circuit: A Novel Druggable Target for Inhibiting CRP-Driven Diabetic Nephropathy - ScienceDirect DPP4/CD32b/NF-κB Circuit: A Novel Druggable Target for Inhibiting CRP-Driven Diabetic Nephropathy - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1525001620304275-fx1.jpg)
DPP4/CD32b/NF-κB Circuit: A Novel Druggable Target for Inhibiting CRP-Driven Diabetic Nephropathy - ScienceDirect
![DPP (Dipeptidyl Peptidase)-4 Inhibitor Attenuates Ang II (Angiotensin II)–Induced Cardiac Hypertrophy via GLP (Glucagon-Like Peptide)-1–Dependent Suppression of Nox (Nicotinamide Adenine Dinucleotide Phosphate Oxidase) 4-HDAC (Histone Deacetylase) 4 ... DPP (Dipeptidyl Peptidase)-4 Inhibitor Attenuates Ang II (Angiotensin II)–Induced Cardiac Hypertrophy via GLP (Glucagon-Like Peptide)-1–Dependent Suppression of Nox (Nicotinamide Adenine Dinucleotide Phosphate Oxidase) 4-HDAC (Histone Deacetylase) 4 ...](https://www.ahajournals.org/cms/asset/2b401de6-f06d-4fe5-8851-33f035c34830/hypertensionaha.119.14400ga1.jpg)
DPP (Dipeptidyl Peptidase)-4 Inhibitor Attenuates Ang II (Angiotensin II)–Induced Cardiac Hypertrophy via GLP (Glucagon-Like Peptide)-1–Dependent Suppression of Nox (Nicotinamide Adenine Dinucleotide Phosphate Oxidase) 4-HDAC (Histone Deacetylase) 4 ...
![IJERPH | Free Full-Text | The Role of DPP-4 Inhibitors in the Treatment Algorithm of Type 2 Diabetes Mellitus: When to Select, What to Expect IJERPH | Free Full-Text | The Role of DPP-4 Inhibitors in the Treatment Algorithm of Type 2 Diabetes Mellitus: When to Select, What to Expect](https://www.mdpi.com/ijerph/ijerph-16-02720/article_deploy/html/images/ijerph-16-02720-sch001.png)
IJERPH | Free Full-Text | The Role of DPP-4 Inhibitors in the Treatment Algorithm of Type 2 Diabetes Mellitus: When to Select, What to Expect
![Dipeptidyl Peptidase-4 at the Interface Between Inflammation and Metabolism - Natasha A Trzaskalski, Evgenia Fadzeyeva, Erin E Mulvihill, 2020 Dipeptidyl Peptidase-4 at the Interface Between Inflammation and Metabolism - Natasha A Trzaskalski, Evgenia Fadzeyeva, Erin E Mulvihill, 2020](https://journals.sagepub.com/cms/10.1177/1179551420912972/asset/images/large/10.1177_1179551420912972-fig1.jpeg)
Dipeptidyl Peptidase-4 at the Interface Between Inflammation and Metabolism - Natasha A Trzaskalski, Evgenia Fadzeyeva, Erin E Mulvihill, 2020
![Frontiers | DPP4 and ACE2 in Diabetes and COVID-19: Therapeutic Targets for Cardiovascular Complications? Frontiers | DPP4 and ACE2 in Diabetes and COVID-19: Therapeutic Targets for Cardiovascular Complications?](https://www.frontiersin.org/files/MyHome%20Article%20Library/569989/569989_Thumb_400.jpg)
Frontiers | DPP4 and ACE2 in Diabetes and COVID-19: Therapeutic Targets for Cardiovascular Complications?
![Comparative Safety of Dipeptidyl Peptidase-4 Inhibitors Versus Sulfonylureas and Other Glucose-lowering Therapies for Three Acute Outcomes | Scientific Reports Comparative Safety of Dipeptidyl Peptidase-4 Inhibitors Versus Sulfonylureas and Other Glucose-lowering Therapies for Three Acute Outcomes | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-018-33483-y/MediaObjects/41598_2018_33483_Fig1_HTML.png)
Comparative Safety of Dipeptidyl Peptidase-4 Inhibitors Versus Sulfonylureas and Other Glucose-lowering Therapies for Three Acute Outcomes | Scientific Reports
![PDF] The effects of DPP-4 inhibitors on vascular endothelial function in diabetes | Semantic Scholar PDF] The effects of DPP-4 inhibitors on vascular endothelial function in diabetes | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/8fb6a87966c41c0daa40f827f9b144c9e29c9f08/79-Figure1.8-1.png)
PDF] The effects of DPP-4 inhibitors on vascular endothelial function in diabetes | Semantic Scholar
![DPP4 Promotes Human Endothelial Cell Senescence and Dysfunction via the PAR2–COX-2–TP Axis and NLRP3 Inflammasome Activation | Hypertension DPP4 Promotes Human Endothelial Cell Senescence and Dysfunction via the PAR2–COX-2–TP Axis and NLRP3 Inflammasome Activation | Hypertension](https://www.ahajournals.org/cms/asset/9f5fe16a-cb9c-43a4-ad5b-21bf6c10d9c3/hypertensionaha.121.18477.fig07.jpg)
DPP4 Promotes Human Endothelial Cell Senescence and Dysfunction via the PAR2–COX-2–TP Axis and NLRP3 Inflammasome Activation | Hypertension
![Development of a treatment selection algorithm for SGLT2 and DPP-4 inhibitor therapies in people with type 2 diabetes: a retrospective cohort study - The Lancet Digital Health Development of a treatment selection algorithm for SGLT2 and DPP-4 inhibitor therapies in people with type 2 diabetes: a retrospective cohort study - The Lancet Digital Health](https://www.thelancet.com/cms/asset/86410633-66f9-484f-820c-0f6c5e3ab6b2/gr1.jpg)
Development of a treatment selection algorithm for SGLT2 and DPP-4 inhibitor therapies in people with type 2 diabetes: a retrospective cohort study - The Lancet Digital Health
![Worsening Heart Failure During the Use of DPP-4 Inhibitors: Pathophysiological Mechanisms, Clinical Risks, and Potential Influence of Concomitant Antidiabetic Medications | JACC: Heart Failure Worsening Heart Failure During the Use of DPP-4 Inhibitors: Pathophysiological Mechanisms, Clinical Risks, and Potential Influence of Concomitant Antidiabetic Medications | JACC: Heart Failure](https://www.jacc.org/cms/asset/d8c3114d-201a-43e8-b42b-ac34be4f2119/fx1.jpg)
Worsening Heart Failure During the Use of DPP-4 Inhibitors: Pathophysiological Mechanisms, Clinical Risks, and Potential Influence of Concomitant Antidiabetic Medications | JACC: Heart Failure
![DPP4 degrade the GLP1 and incretion, which leads to suppression of the... | Download Scientific Diagram DPP4 degrade the GLP1 and incretion, which leads to suppression of the... | Download Scientific Diagram](https://www.researchgate.net/publication/343774145/figure/fig2/AS:926657976225795@1597943886841/DPP4-degrade-the-GLP1-and-incretion-which-leads-to-suppression-of-the-insulin.png)